Edition:
United States

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

6.24USD
2:53pm EST
Change (% chg)

$0.08 (+1.22%)
Prev Close
$6.16
Open
$6.20
Day's High
$6.25
Day's Low
$6.20
Volume
3,700
Avg. Vol
13,698
52-wk High
$9.25
52-wk Low
$3.70

GLYC.OQ

Chart for GLYC.OQ

About

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. The Company is developing its lead drug candidate, GMI-1070 (Rivipansel), for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $142.08
Shares Outstanding(Mil.): 23.07
Dividend: --
Yield (%): --

Financials

  GLYC.OQ Industry Sector
P/E (TTM): -- 42.12 30.77
EPS (TTM): -1.61 -- --
ROI: -70.75 -0.81 15.23
ROE: -71.55 -1.52 16.56

BRIEF-GlycoMimetics posts Q3 loss of $0.34/share

* GlycoMimetics reports third quarter 2016 results and progress in clinical development

Nov 04 2016

BRIEF-Glycomimetics doses first patient in Phase 1 clinical trial of drug candidate GMI-1271 for multiple myeloma

* Glycomimetics Doses First Patient In Phase 1 Clinical Trial Of Drug Candidate GMI-1271 for multiple myeloma

Sep 14 2016

BRIEF-GlycoMimetics announces publication of preclinical data

* Announces publication of preclinical data showing drug candidate GMI-1271 reduces inflammatory responses after heart attack

Aug 16 2016

BRIEF-GlycoMimetics reports qtrly loss per share of $0.41

* Q2 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Aug 04 2016

BRIEF-Glycomimetics announces pricing of public offering

* Says public offering of 3.30 million common shares priced at $6.10 per share

Jun 17 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $110.56 -1.50
Novartis AG (NOVN.S) CHF68.75 -0.65
Pfizer Inc. (PFE.N) $30.99 -0.57
Merck & Co., Inc. (MRK.N) $59.78 -0.50
Roche Holding Ltd. (ROG.S) CHF221.20 -2.30
Roche Holding Ltd. (RO.S) CHF225.20 -3.00
Bayer AG (BAYGn.DE) €90.10 +1.94
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates